Alveolar Soft Part Sarcoma

Search Trials
Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
Status:
Recruiting
Last Changed:
Feb 9, 2022
First Changed:
May 5, 2017
Disease(s):
Metastatic Alveolar Soft Part Sarcoma
Intervention(s):
AtezolizumabBevacizumab
Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas
Status:
Recruiting
Last Changed:
Nov 18, 2021
First Changed:
Sep 11, 2017
Disease(s):
Soft Tissue Sarcoma
Intervention(s):
Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]Nivolumab 100 MG/10 ML [Opdivo]EpirubicinIfosfamideDoxorubicinDacarbazineCisplatinMethotrexate
Trial of Sunitinib Plus Nivolumab After Standard Treatment in Advanced Soft Tissue and Bone Sarcomas
Status:
Recruiting
Last Changed:
May 4, 2021
First Changed:
Sep 11, 2017
Disease(s):
Soft Tissue Sarcoma
Intervention(s):
Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]Nivolumab 100 MG/10 ML [Opdivo]
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
Status:
Completed
Last Changed:
Sep 27, 2021
First Changed:
Feb 14, 2012
Disease(s):
Adult Alveolar Soft Part Sarcoma
Intervention(s):
GemcitabineGemcitabine HydrochlorideLaboratory Biomarker AnalysisPazopanibPazopanib HydrochloridePlacebo Administration
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma – MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Status:
Recruiting
Last Changed:
Feb 14, 2022
First Changed:
May 30, 2019
Disease(s):
Soft Tissue Sarcoma
Intervention(s):
Patient with Soft Tissue Sarcoma

Connect. Empower. Inspire.